{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:04:06Z","timestamp":1783699446239,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019346","name":"Instituto Nacional de Cancerolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clnesp.2025.09.028","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:13:26Z","timestamp":1758788006000},"page":"413-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Phase angle as a prognostic factor of survival in patients with metastatic prostate cancer"],"prefix":"10.1016","volume":"70","author":[{"given":"Tanya","family":"Cauz-Valero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5191-744X","authenticated-orcid":false,"given":"Ema Elvira","family":"Herrera-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Scavuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Calvo-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Ram\u00edrez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonso","family":"Hurtado-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Reynoso-Nover\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana Aline","family":"P\u00e9rez-Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"J\u00edmenez-R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2025.09.028_bib1","series-title":"Cancer today","author":"Ferlay","year":"2024"},{"issue":"3","key":"10.1016\/j.clnesp.2025.09.028_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"10.1016\/j.clnesp.2025.09.028_bib3","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.3390\/cancers16213675","article-title":"Lethal prostate cancer in Mexico: data from the Can.Prost Mexican registry and a project for early detection","volume":"16","author":"Jimenez Rios","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.clnesp.2025.09.028_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41391-018-0079-0","article-title":"Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations","volume":"22","author":"Crawford","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clnesp.2025.09.028_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41585-025-01002-0","article-title":"Assessing the effects of prostate cancer therapies on cardiovascular health","author":"Tisseverasinghe","year":"2025","journal-title":"Nat Rev Urol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.09.028_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate cancer","volume":"294","author":"Sharifi","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.clnesp.2025.09.028_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.2002.01551.x","article-title":"Long-term effects of androgen deprivation therapy in prostate cancer patients","volume":"56","author":"Basaria","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.clnesp.2025.09.028_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1746-1596-1-4","article-title":"Prognostic factors in prostate cancer","volume":"1","author":"Buhmeida","year":"2006","journal-title":"Diagn Pathol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.09.028_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.prnil.2019.11.002","article-title":"Relationship between body composition and hormone sensitivity for androgen deprivation therapy in patients with metastatic prostate cancer","volume":"8","author":"Kashiwagi","year":"2020","journal-title":"Prostate Int"},{"issue":"2","key":"10.1016\/j.clnesp.2025.09.028_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41391-018-0099-9","article-title":"Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence?","volume":"22","author":"Barnes","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.clnesp.2025.09.028_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/10428194.2015.1136741","article-title":"Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy","volume":"59","author":"Orgel","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"25","key":"10.1016\/j.clnesp.2025.09.028_bib12","first-page":"S2405","article-title":"Defining obesity in the context of cancer: thinking beyond body mass index","volume":"14","author":"Gulati","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.clnesp.2025.09.028_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21095-6","article-title":"Phase angle obtained via bioelectrical impedance analysis and objectively measured physical activity or exercise habits","volume":"12","author":"Yamada","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clnesp.2025.09.028_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11154-022-09780-3","article-title":"Bioimpedance basics and phase angle fundamentals","volume":"24","author":"Ward","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"10.1016\/j.clnesp.2025.09.028_bib15","first-page":"311","article-title":"Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations","volume":"8","author":"Barbosa-Silva","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"10.1016\/j.clnesp.2025.09.028_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11154-023-09799-0","article-title":"Phase angle in applications of bioimpedance in health and disease","volume":"24","author":"Lukaski","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"issue":"22","key":"10.1016\/j.clnesp.2025.09.028_bib17","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.3390\/nu15224792","article-title":"Bioelectrical impedance analysis (BIA) for the assessment of body composition in oncology: a scoping review","volume":"15","author":"Branco","year":"2023","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.clnesp.2025.09.028_bib18","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/medicina58121779","article-title":"Changes in body weight, body composition, phase angle, and resting metabolic rate in male patients with stage IV non-small-cell lung cancer undergoing therapy","volume":"58","author":"Detopoulou","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"10.1016\/j.clnesp.2025.09.028_bib19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/01635581.2017.1367939","article-title":"Assessment and impact of phase angle and sarcopenia in palliative cancer patients","volume":"69","author":"P\u00e9rez Camargo","year":"2017","journal-title":"Nutr Cancer"},{"issue":"6","key":"10.1016\/j.clnesp.2025.09.028_bib20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.clnu.2004.09.012","article-title":"ESPEN. Bioelectrical impedance analysis\u2014part II: utilization in clinical practice","volume":"23","author":"Kyle","year":"2004","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2025.09.028_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/01635581.2017.1299880","article-title":"Phase angle of bioelectrical impedance analysis as prognostic factor in palliative care patients at the national cancer Institute in Mexico","volume":"69","author":"P\u00e9rez Camargo","year":"2017","journal-title":"Nutr Cancer"},{"issue":"5","key":"10.1016\/j.clnesp.2025.09.028_bib22","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1016\/j.clnu.2021.01.027","article-title":"Is phase angle a valuable prognostic tool in cancer patients' survival? A systematic review and meta-analysis of available literature","volume":"40","author":"Arab","year":"2021","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2025.09.028_bib23","first-page":"161","article-title":"Phase angle as a prognostic factor in patients with cancer: a systematic review of the existing evidence via a meta-analysis","volume":"42","author":"Kong","year":"2025","journal-title":"Nutr Hosp"},{"issue":"3","key":"10.1016\/j.clnesp.2025.09.028_bib24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/01635581.2023.2165693","article-title":"Investigation on nutrition status and its clinical outcome of common cancers, INSCOC project. Association of phase angle with overall survival in patients with cancer: a prospective multicenter cohort study","volume":"75","author":"Zou","year":"2023","journal-title":"Nutr Cancer"},{"issue":"2","key":"10.1016\/j.clnesp.2025.09.028_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/healthcare11020246","article-title":"Phase angle and nutritional status: the impact on survival and health-related quality of life in locally advanced uterine cervical cancer","volume":"11","author":"Gonz\u00e1lez-Barba","year":"2023","journal-title":"Healthcare"},{"issue":"10","key":"10.1016\/j.clnesp.2025.09.028_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.31083\/j.fbl2910345","article-title":"Re-assessing the role of platelet activating factor and its inflammatory signaling and inhibitors in cancer and anti-cancer strategies","volume":"29","author":"Tsoupras","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.clnesp.2025.09.028_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1237086","article-title":"Associations of phase angle with platelet-activating factor metabolism and related dietary factors in healthy volunteers","volume":"10","author":"Detopoulou","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2025.09.028_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112468","article-title":"Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. Phase angle: a robust predictor of malnutrition and poor prognosis in gastrointestinal cancer","volume":"125","author":"Yang","year":"2024","journal-title":"Nutrition"},{"issue":"6","key":"10.1016\/j.clnesp.2025.09.028_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/ncp.10100","article-title":"The prognostic role of phase angle in advanced cancer patients: a systematic review","volume":"33","author":"Pereira","year":"2018","journal-title":"Nutr Clin Pract"},{"issue":"3","key":"10.1016\/j.clnesp.2025.09.028_bib30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jpainsymman.2016.09.016","article-title":"Association between multi-frequency phase angle and survival in patients with advanced cancer","volume":"53","author":"Hui","year":"2017","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"10.1016\/j.clnesp.2025.09.028_bib31","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/ajcn\/80.6.1634","article-title":"Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer","volume":"80","author":"Gupta","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.09.028_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1061996","article-title":"Sex differences in the association of phase angle and lung cancer mortality","volume":"9","author":"Shi","year":"2022","journal-title":"Front Nutr"},{"issue":"9","key":"10.1016\/j.clnesp.2025.09.028_bib33","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.5455\/ijmsph.2016.30122015335","article-title":"Bioelectric impedance phase angle in carcinoma prostate \u2013 a hospital-based study","volume":"5","author":"Tyagi","year":"2016","journal-title":"Int J Med Sci Publ Health"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725029511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725029511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:38:11Z","timestamp":1764405491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725029511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S2405457725029511"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.09.028","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase angle as a prognostic factor of survival in patients with metastatic prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}